Evidence map›Paper›PMID 33616693›Full record

ArticleSocial psychiatry and psychiatric epidemiology2021

A nationwide evaluation of the prevalence of and risk factors associated with anxiety, depression and insomnia symptoms during the return-to-work period of coronavirus disease 2019 in China.

Shu Wang, Yuan Zhang, Yuguang Guan, Wei Ding, Yao Meng, Huiting Hu, Zhenhua Liu, Xianwei Zeng, Minzhong Wang

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Social psychiatry and psychiatric epidemiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 5 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 5 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Returning to Work after the COVID-19 Pandemic Earthquake: A Systematic Review.International journal of environmental research and public health · 2022
    Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Shu WangDepartment of Neurosurgery, SanBo Brain Hospital, Capital Medical University, Beijing, 100093, China.ORCID http://orcid.org/0000-0002-5914-0804
Yuan ZhangDalian Medical University, Dalian, 116044, Liaoning, China.ORCID http://orcid.org/0000-0001-5236-2626
Yuguang GuanDepartment of Neurosurgery, SanBo Brain Hospital, Capital Medical University, Beijing, 100093, China.
Wei DingDepartment of Neurology, Liaocheng People's Hospital, Liaocheng, 252000, Shandong, China.
Yao MengDepartment of Neurology, The First Affiliated Hospital of Shandong First Medical University, Jinan, 250014, Shandong, China.
Huiting HuDepartment of Neurology, Heze Mudan People's Hospital, Heze, 274000, Shandong, China.
Zhenhua LiuSleep Medicine Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.
Xianwei ZengDepartment of Neurosurgery, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, China.
Minzhong WangDepartment of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China. wmzwlq@163.com.ORCID http://orcid.org/0000-0002-5765-182X
Capital Medical University · CNShandong Provincial Hospital · CNDalian Medical University · CNHeze Municipal Hospital · CNLiaocheng People's Hospital · CNQilu Hospital of Shandong University · CNShandong First Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the prevalence of and risk factors associated with anxiety, depression, and insomnia symptoms during the return-to-work period of coronavirus disease 2019 in China.

methodsThe authors conducted a large-scale, nationwide, multicenter, cross-sectional study in China. A population-based quota and snowball sampling were designed to recruit a representative sample. Online questionnaires and telephone reviews were used to collect characteristics and assess psychological and sleep problems. Anxiety, depression, and insomnia symptoms were measured by the generalized anxiety disorder-7, patient health questionnaire-9, and insomnia severity index tools.

resultsA total of 42,000 participants were recruited from 15 centers, and 36,795 valid questionnaires were received. Generally, 18.3, 14.9, and 17.9% of the participants had anxiety, depression, and insomnia symptoms, respectively, and 2.2-2.7% had severe symptoms. Engaging in outside activity once in ≥ 30 days (OR = 2.719, OR = 2.074, OR = 2.225) and age 50-64 years (OR = 2.431, OR = 1.936, OR = 2.036) were common risk factors for anxiety, depression and insomnia symptoms. Living in Hubei Province (OR = 1.304, OR = 1.242) was a common risk factor for anxiety and insomnia symptoms. Working as frontline medical staff (OR = 2.150) was another risk factor for anxiety symptoms. The health education rate of the samples reached 98.9%. However, the psychological intervention rate was only 16.2%, and 2.5% received targeted interventions.

conclusionsAn increasing number of people might have psychological and sleep problems. However, the current psychological interventions are not sufficient. Efforts should be made to strengthen interventions for high-risk populations.

Indexed as

COVID-19Sleep Initiation and Maintenance DisordersAnxietyAnxiety DisordersChinaCross-Sectional StudiesDepressionHumansMiddle AgedPrevalenceReturn to WorkRisk FactorsSARS-CoV-2AnxietyCoronavirus disease 2019Cross-sectionalDepressionInsomnia

Identifiers

PMID33616693
PMCPMC7898251
OpenAlexW3131873026

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.